Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tramadol controlled release - Labopharm

Drug Profile

Tramadol controlled release - Labopharm

Alternative Names: Contramal Uno; Dolpar; Durotram XR; Monoalgic L.P.; Monotramal L.P.; Noax Uno; NS-24; Once-daily tramadol; Once-daily tramadol MP; Onetram; Ryzolt; Tradorec XL; TramaConti CR; Tramadol CR; Tramadol extended release; Tramadolor einmal täeglich; Tridural; Unitrama

Latest Information Update: 24 Apr 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Labopharm
  • Developer Altus Formulation Inc; Nippon Shinyaku
  • Class Anisoles; Antidepressants; Cyclohexanols; Dimethylamines; Erectile dysfunction therapies; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid mu receptor agonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Cancer pain; Pain

Most Recent Events

  • 08 Mar 2016 Biomarkers information updated
  • 26 Mar 2015 Registered for Cancer pain and Chronic pain in Japan (PO)
  • 16 Jun 2014 Preregistration for Cancer pain in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top